Online
| Post a Message | Explore Forums | Browse Stock Messages | Hot Discussions | Top rated Messages | Top Boarders | |
|
|
|
GlaxoSmithKline Pharmaceuticals
Smithkline Beecham
Posted by :
psgsTracked by: 0 Boarder
hi rocky bhai,
yes...its a very slow stock. inspite of exiting from the fine chem business last year, the profits yoy for this quarter was up only by 20%. which is not very special at all for investors. volumes are very thin in this counter. there are no triggers. still there are no launches of their blockbuster drugs which was being talked about since 2 years or so. the stock is languishing. but no losses for investors as the stock is also not falling much. but its boring to have a stock like this. nodoubt there is huge value. but its only for very long term investors i guess. these mnc managements are extremely conservative and sometimes they don't provide any triggers in the counter. deepak parekh likely to step down according to some reports, so the new next chairman may bring in some changes and the stock may react thereafter. hold for long term.
swamy.
...
In reply to:
Smithkline Beecham
Posted by :
rocky_421001
I'm holding it 500 shares since the buyback happened at 800 per share, so i genreally track technically and keep trading in that. Other wise its my investment. But i dont think it has really performed with market expectations. A good dividend yield thats it.
Regards,
R.C. 
Smithkline Beecham
Posted by : rocky_421001Tracked by: 0 Boarder
I'm holding it 500 shares since the buyback happened at 800 per share, so i genreally track technically and keep trading in that. Other wise its my investment. But i dont think it has really performed with market expectations. A good dividend yield thats it.
Regards,
R.C....
Interim devidend/bonus
Posted by : bhoogi,bhoogiTracked by: 0 Boarder
Really this counter is disappointing the share holders because there is no encouraging announcement either the way !...
BSE Announcements on GlaxoSmithKline
Posted by : MMB MessengerTracked by: 0 Boarder
GlaxoSmithKline Pharmaceuticals Ltd has announced the following Unaudited results for the quarter ended June 30, 2008:
The Company has posted a net profit of Rs 1148.60 million for the quarter ended June 30, 2008 where as the same was at Rs 964.30 million for the quarter ended June 30, 2007. Total Income is Rs 4428.00 million for the quarter ended June 30, 2008 where as the same was at Rs 4151.00 million for the quarter ended June 30, 2007.
The growth in Net Sales (net of excise and excluding the Fine Chemicals business) was 11.2% during the quarter ended June 30, 2008. The growth in Gross Sales (excluding the Fine Chemicals business) during the quarter ended June 30, 2008 was impacted due to lower selling prices as a result of the excise benefit passed on to the consumer. Profit before Tax and Exceptional items grew by 19.2% during the quarter on a comparable basis.
The figures for the current period are not comparable with those of the previous period, In view of the sale of the Fine Chemicals business on September 30, 2007....
NSE Announcements on GlaxoSmithKline
Posted by : MMB MessengerTracked by: 0 Boarder
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding the standalone Results for the half year ended on 30-JUN-2008 as follows: Net Sales of Rs. 83501 lacs for half year ending on 30-JUN-2008 against Rs. 81707 lacs for the half year ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 23613 lacs for the half year ending on 30-JUN-2008 against Rs. 20775 lacs for the half year ending on 30-JUN-2007....
NSE Announcements on GlaxoSmithKline
Posted by : MMB MessengerTracked by: 0 Boarder
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 41690 lacs for quarter ending on 30-JUN-2008 against Rs. 39561 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 11486 lacs for the quarter ending on 30-JUN-2008 against Rs. 9643 lacs for the quarter ending on 30-JUN-2007....
Smithkline beecham
Posted by : psgsTracked by: 0 Boarder
hello...rocky bhai,
who is trading in this first of all. and who is setting targets.
is it your target 1200. why exit when it is outperforming the markets
so well. its a safe heaven like stock for long term.
my target is 1800. i would say HOLD.
swamy....
In reply to:
Smithkline Beecham
Posted by : rocky_421001
I'm holding it 500 shares since the buyback happened at 800 per share, so i genreally track technically and keep trading in that. Other wise its my investment. But i dont think it has really performed with market expectations. A good dividend yield thats it.
Regards,
R.C.
More from the Pharmaceuticals Sector
see more
Boarders tracking GlaxoSmithKline
News Updates on GlaxoSmithKline
